POTENTIAL STUDY DRUG INTERACTIONS IN PATIENTS HYPERTENSIVE

Sally Cristina Moutinho Monteiro, Ilka Kassandra Pereira Belfort, Wandson Rodrigues Sousa, Clemilson da Silva Barros, Karla Valéria Santos de Campos

Abstract


Hypertension is a chronic elevation of systolic and diastolic blood pressure and is probably the most common chronic disease today. Most hypertensive patients use several drugs, increasing the risk of drug interactions. These interactions can lead to morbidity and mortality if preventive measures are not taken. The objective was to investigate potential drug interactions in patients with hypertension and report the necessary therapeutic interventions. Was conducted a quantitative observational cross-sectional study with 60 hypertensive of System of Registration and Monitoring Hypertensive Diabetics SIS-HIPERDIA, linked to a Basic Health Unit (UBS). The study population was predominantly female, mulatto color, with low education and low family income. It was found 70 potential drug interactions at varying levels, highlighting the moderate interactions (84.28%). The medications more involved in potential drug interactions were ASA + Losartan and Hydrochlorothiazide + Captopril, which could cause reduction of antihypertensive efficacy by reduction of renal prostaglandins. It was concluded that it is appropriate to adopt collaborative strategies among physicians, pharmacists, nurses, nutritionists and fitness trainers in order to develop awareness actions of the need for changes in lifestyle and therapeutic adherence of hypertensive patients.


Keywords


atenção farmacêutica; hipertensão; interações medicamentosas



DOI: http://dx.doi.org/10.14450/2318-9312.v27.e2.a2015.pp117-125

Refbacks

  • There are currently no refbacks.


Copyright (c) 2015 Infarma - Pharmaceutical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Infarma - Ciências Farmacêuticas

ISSN - 2318-9312 (Versão eletrônica)

ISSN - 0104-0219 (Versão impressa)

Conselho Federal de Farmácia - CFF

SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF

CEP: 71635-615 - Fone: (61)3878-8751

e-mail:infarma@cff.org.br

Diretoria

Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia

Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia

João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia

Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia